Arecor Therapeutics plc (LON:AREC – Get Free Report) reached a new 52-week low on Monday . The company traded as low as GBX 86 ($1.10) and last traded at GBX 91.40 ($1.17), with a volume of 6523 shares traded. The stock had previously closed at GBX 95 ($1.21).
Arecor Therapeutics Trading Down 3.8 %
The firm has a market capitalization of £28.00 million, a price-to-earnings ratio of -326.43 and a beta of -0.15. The company has a fifty day moving average price of GBX 112.65 and a 200-day moving average price of GBX 133.41. The company has a current ratio of 2.17, a quick ratio of 6.24 and a debt-to-equity ratio of 3.55.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- High Flyers: 3 Natural Gas Stocks for March 2022
- How to Invest in Silver: A Beginner’s Guide
- Are Penny Stocks a Good Fit for Your Portfolio?
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- Stock Splits, Do They Really Impact Investors?
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
